Systemic therapy for advanced hepatocellular carcinoma: a review
- 31 July 2004
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 40 (10), 1474-1484
- https://doi.org/10.1016/j.ejca.2004.02.027
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Phase II study of thalidomide in patients with unresectable hepatocellular carcinomaCancer, 2004
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Assessing clinical benefit in the treatment of pancreas cancer: Gemcitabine compared to 5-fluorouracilEuropean Journal Of Cancer, 1997
- A Phase I/II trial of epirubicin and high dose tamoxifen as a potential modulator of multidrug resistance in advanced hepatocellular carcinomaEuropean Journal Of Cancer, 1996
- Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumoursEuropean Journal Of Cancer, 1995
- Cytotoxicity of CPT-11 for gastrointestinal cancer cells cultured on fixed-contact-sensitive platesAnti-Cancer Drugs, 1995
- Treatment of unresectable hepatocellular carcinoma with a combination of human recombinant α-2b interferon and doxorubicin: Results of a pilot studyEuropean Journal Of Cancer, 1994
- Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinomaEuropean Journal Of Cancer, 1994
- Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinomaDigestive Diseases and Sciences, 1992
- Overexpression of the MDR1 Gene and P-Glycoprotein in Human Hepatocellular CarcinomaJNCI Journal of the National Cancer Institute, 1992